Please login to the form below

Not currently logged in
Email:
Password:

Jan Reiss moves from PAN Unlimited to IGNIFI

She joins as strategic business development director

IGNIFI Jan ReissUK-based IGNIFI has appointed Jan Reiss as its new strategic development director.

In this newly created role, Reiss will be responsible for driving new business and overseeing the strategic development of existing client partnerships.

Dave Watson, managing director of IGNIFI, said: “Jan's appointment is strategically significant, and will help us fuel growth and development in the pharmaceutical and healthcare sector – a key part of our health, active lifestyle and wellbeing focus.

“Jan's experience and insight enhances our existing skill set and will help bring our capabilities to a wider audience.”

Prior to joining the creative agency, Reiss served as an associate director in business development at PAN Unlimited, now PAN DJM Unlimited.

She also brings 11 years of client service experience in healthcare communications, having worked at CDM London, DDB Remedy, Langland and Medicus International.

Reiss said: “I am thrilled to have joined the team at IGNIFI. … there is an ethos at IGNIFI that we want our clients to truly enjoy working with us, which manifests itself in great client-agency relationship, and makes working here thoroughly enjoyable.”

10th February 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics